Pharmabiz51m
Bausch + Lomb receives US FDA approval for enVista Envy full range of vision intraocular lens
Bausch + Lomb receives US FDA approval for enVista Envy full range of vision intraocular lens: Vaughan, Ontario Tuesday, October 15, 2024, 17:00 Hrs [IST] Bausch + Lomb Corporatio ...
Pharmabiz1h
MedGenome marks 10 years of genomics in India, works to further its research and diagnostics in disease prevention
MedGenome marks 10 years of genomics in India, works to further its research and diagnostics in disease prevention: Our Bureau, Bengaluru Tuesday, October 15, 2024, 16:40 Hrs [IST ...
Pharmabiz1h
Ardena inks agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey
Ardena inks agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey: Ghent, Belgium Tuesday, October 15, 2024, 16:00 Hrs [IST] Ardena, a specialist pha ...
Pharmabiz2h
C-CAMP with ICARS to support innovative solutions to address the challenge of AMR across the One Health domain
C-CAMP with ICARS to support innovative solutions to address the challenge of AMR across the One Health domain: Our Bureau, Bengaluru Tuesday, October 15, 2024, 15:15 Hrs [IST] Th ...
Pharmabiz2h
Ampath collaborates with Innocent Hearts Hospital to expand diagnostic services in Jalandhar
Ampath collaborates with Innocent Hearts Hospital to expand diagnostic services in Jalandhar: Our Bureau, Bengaluru Tuesday, October 15, 2024, 15:50 Hrs [IST] American Institute o ...
Pharmabiz2h
HealthPlix gets HIPAA certification, reinforcing its efforts in patient data privacy and security
HealthPlix gets HIPAA certification, reinforcing its efforts in patient data privacy and security: Our Bureau, Bengaluru Tuesday, October 15, 2024, 15:30 Hrs [IST] HealthPlix Tech ...
Pharmabiz2h
Lundbeck to buy clinical-stage biopharma company, Longboard Pharmaceuticals for USD 2.6 billion
Lundbeck to buy clinical-stage biopharma company, Longboard Pharmaceuticals for USD 2.6 billion: Valby, Denmark Tuesday, October 15, 2024, 15:00 Hrs [IST] H. Lundbeck A/S (Lundbec ...
Pharmabiz3h
Dizal gets China NMPA breakthrough therapy designation for sunvozertinib to treat NSCLC with EGFR exon 20 insertion mutations
Dizal gets China NMPA breakthrough therapy designation for sunvozertinib to treat NSCLC with EGFR exon 20 insertion mutations: Shanghai, China Tuesday, October 15, 2024, 14:30 Hrs ...
Pharmabiz3h
Exelixis, Merck enter clinical development collaboration to evaluate zanzalintinib in combo with Keytruda in HNSCC and in combo with Welireg in RCC
Alameda, California Tuesday, October 15, 2024, 14:00 Hrs [IST] ...
Pharmabiz4h
Lupin introduces generic Pred Forte in United States
Global pharma major Lupin Limited (Lupin) announced the launch of the first generic version of Pred Forte (prednisolone acetate) ophthalmic suspension USP, 1% in the United States. Being the first ...
Pharmabiz4h
US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx
US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx: Brussels, Belgium Tuesday, October 15, 2024, 13:00 Hrs [IST] UCB, a global biopharmaceutical compa ...
Pharmabiz5h
Majority of children with SMA treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate
Majority of children with SMA treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate ...